1.0500
-0.0500
(-4.55%)
At close: April 15 at 4:00:01 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BARTON RUSSELL Chief Operating Officer | Sale | Jan 21, 2025 | 136,117 |
| DOHERTY JAMES J President | Stock Award(Grant) | Jan 6, 2025 | 62,600 |
| IVES JEFFREY L Director | Sale | Aug 17, 2023 | 0 |
| MEISNER DEREK M Officer | Sale | Jan 21, 2025 | 161,127 |
| O'CONNELL DANIEL JOSEPH Chief Executive Officer | Sale | Jan 21, 2025 | 667,488 |
| RA CAPITAL MANAGEMENT, L.P. Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Jul 21, 2023 | -- |
| SCHACTERLE AMY PH.D. Officer | Stock Award(Grant) | Jan 6, 2025 | 8,800 |
| SIEMERS ERIC M.D. Officer | Sale | Jan 21, 2025 | 170,298 |
| ZUGA MATT Chief Financial Officer | Sale | Jan 23, 2025 | 231,744 |
Related Tickers
IKNA Ikena Oncology, Inc.
1.1400
-2.56%
ANTX AN2 Therapeutics, Inc.
1.2600
-3.82%
ACRV Acrivon Therapeutics, Inc.
2.1500
+43.33%
PRLD Prelude Therapeutics Incorporated
0.7523
+8.40%
SEPN Septerna, Inc.
6.29
+3.62%
ACXP Acurx Pharmaceuticals, Inc.
0.3800
-0.63%
KYTX Kyverna Therapeutics, Inc.
1.9850
-10.99%
IOBT IO Biotech, Inc.
0.8879
-1.12%
GLUE Monte Rosa Therapeutics, Inc.
4.4300
+0.45%
ABP Abpro Corporation
0.2630
-10.85%